Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Stoke Therapeutics (STOK) Depreciation & Amortization (CF) (2022 - 2025)

Stoke Therapeutics has reported Depreciation & Amortization (CF) over the past 4 years, most recently at $435000.0 for Q4 2025.

  • For Q4 2025, Depreciation & Amortization (CF) fell 17.3% year-over-year to $435000.0; the TTM value through Dec 2025 reached $1.8 million, down 17.32%, while the annual FY2025 figure was $1.8 million, 17.32% down from the prior year.
  • Depreciation & Amortization (CF) for Q4 2025 was $435000.0 at Stoke Therapeutics, down from $442000.0 in the prior quarter.
  • Over five years, Depreciation & Amortization (CF) peaked at $637000.0 in Q3 2023 and troughed at $247000.0 in Q1 2022.
  • A 4-year average of $496625.0 and a median of $533000.0 in 2024 define the central range for Depreciation & Amortization (CF).
  • Biggest five-year swings in Depreciation & Amortization (CF): soared 141.7% in 2023 and later decreased 18.61% in 2025.
  • Year by year, Depreciation & Amortization (CF) stood at $563000.0 in 2022, then rose by 10.83% to $624000.0 in 2023, then decreased by 15.71% to $526000.0 in 2024, then decreased by 17.3% to $435000.0 in 2025.
  • Business Quant data shows Depreciation & Amortization (CF) for STOK at $435000.0 in Q4 2025, $442000.0 in Q3 2025, and $446000.0 in Q2 2025.